Robert Brackner

In laboratories around the globe, scientists are diligently researching the limitless potential of advanced therapeutic medicinal products (ATMPs). These groundbreaking therapies are changing the face of healthcare by harnessing the potential of the human body for healing. Using cells, proteins, antibodies, tissues and nucleic acids as “living” therapies is simultaneously promising, but also brings unique challenges from a manufacturing, supply chain, and patient treatment standpoint.